These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6973224)

  • 1. Lymphocytotoxic anti-LewisbH antibody.
    Hudelson B; Liu J; Ocariz J; Martin D; Slater LM
    Transplantation; 1981 Jun; 31(6):449-51. PubMed ID: 6973224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Another case of a lymphocytotoxic antibody with blood group A1 Leb and A Led associated specificity.
    Staub Nielsen L; Eiberg H; Mohr J
    Tissue Antigens; 1983 Mar; 21(3):177-83. PubMed ID: 6190260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABH and Lewis antigens on lymphocytes: screening of pregnant women's sera with the B-cell cytotoxicity test.
    Park MS; Oriol R; Nakata S; Terasaki PI; Ford R; Bernoco D
    Transplant Proc; 1979 Dec; 11(4):1947-9. PubMed ID: 394439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bone marrow transplant with an acquired anti-Le(a): a case study.
    Myser T; Steedman M; Hunt K; Strohm P; Williams M; Kennedy M
    Hum Immunol; 1986 Oct; 17(2):102-6. PubMed ID: 3531108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunochemical study of the lymphocyte A, Atri system.
    Marcelli-Barge A; Strecker G; Poirier JC; Dausset J
    Haematologia (Budap); 1980; 13(1-4):23-31. PubMed ID: 6166521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytotoxic definition of combined ABH and Lewis antigens and their transfer from sera to lymphocytes.
    Oriol R; Danilovs J; Lemieux R; Terasaki P; Bernoco D
    Hum Immunol; 1980 Oct; 1(3):195-205. PubMed ID: 6167548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific removal of anti-red cell blood group activity from anti-HLA lymphocytotoxic sera and purification of anti-A and anti-B antibodies with lymphocytotoxic activity.
    Bernoco M; Bernoco D; Danilovs J; Terasaki PI; Mollicone R; Oriol R
    Tissue Antigens; 1985 Aug; 26(2):147-52. PubMed ID: 3904079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The routine use of soluble Lewis antigens in the identification of Lewis system antibodies.
    Shulman IA; Nakayama R
    Transfusion; 1993 Jan; 33(1):37-41. PubMed ID: 8424265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients.
    Boratyńska M; Banasik M; Hałoń A; Patrzałek D; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2711-4. PubMed ID: 18021965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of a non-HLA serum towards lymphocytes from blood group B, Lewis negative and ABH secretor individuals.
    Mittal KK; Naik S
    Acta Anthropogenet; 1983; 7(3):249-56. PubMed ID: 6680662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light-microscopic examination of ABH and Lewis antigens in human tracheal and epiglottic glands using the avidin-biotin-peroxidase complex technique.
    Nishi K; Fechner G; Rand S; Brinkmann B
    Z Rechtsmed; 1989; 102(4):255-62. PubMed ID: 2652935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies.
    Singal DP; Blajchman MA; Joseph S; Roberge B; Smith EK; Ludwin D
    Clin Exp Immunol; 1988 May; 72(2):222-7. PubMed ID: 2970351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T and B lymphocyte subpopulations with HLA-DR surface molecules in rheumatoid arthritis, using a monoclonal lymphocytotoxic antibody. Poorly and highly developed rheumatoid arthritis].
    Mercier P; Dallest R; Olmeta C; Gaborit P; Gatti P; Roux H
    Rev Rhum Mal Osteoartic; 1981 Nov; 48(11):713-9. PubMed ID: 6975966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type.
    Pour PM; Tempero MM; Takasaki H; Uchida E; Takiyama Y; Burnett DA; Steplewski Z
    Cancer Res; 1988 Oct; 48(19):5422-6. PubMed ID: 3166398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of lymphocytotoxic antibodies on the outcome of kidney transplantation].
    Drannik GN; Driianskaia VE; Montag TS
    Urol Nefrol (Mosk); 1990; (1):28-31. PubMed ID: 2336753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological and chemical specificities of twelve monoclonal anti-Lea and anti-Leb antibodies.
    Good AH; Yau O; Lamontagne LR; Oriol R
    Vox Sang; 1992; 62(3):180-9. PubMed ID: 1609521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific anti-donor lymphocytotoxic antibodies following blood transfusion from nonrelated donors.
    Ettenger RB; Jordan SC; Arnett J; Robinson BJ; Fine RN
    Transplant Proc; 1982 Jun; 14(2):347-8. PubMed ID: 7051476
    [No Abstract]   [Full Text] [Related]  

  • 18. ABH and Lewis antigen and antibody expression after bone marrow transplantation.
    Needs ME; McCarthy DM; Barrett J
    Acta Haematol; 1987; 78(1):13-6. PubMed ID: 3116802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion significance of Lewis system antibodies. Success in transfusion with crossmatch-compatible blood.
    Waheed A; Kennedy MS; Gerhan S; Senhauser DA
    Am J Clin Pathol; 1981 Sep; 76(3):294-8. PubMed ID: 7282630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-B lymphocytotoxins in renal-allograft rejection.
    Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
    N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.